[{"Assets_0_Q1_USD":"21195900000.0","CIK":"875045","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"3.47","EarningsPerShareDiluted_1_Q1_USD":"3.46","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"32775642095.0","MinorityInterest_0_Q1_USD":"-11600000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"235200000.0","NetIncomeLoss_1_Q1_USD":"747600000.0","OfficialName":"Biogen Inc. Common Stock","ProfitLoss_1_Q1_USD":"747500000.0","RevenuesConverted_1_Q1_USD":"2810700000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"11467400000.0","StockholdersEquity_0_Q1_USD":"11479000000.0","Ticker":"BIIB","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"215900000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"215600000.0","filed":"20170425","footnote":null,"form":"10-Q","fp":"Q1","fy":"2017.0","name":"BIOGEN INC.","period":"20170331","qtrs":"0","uom":"USD"}]